586-16-3

Basic information

• Product Name: 3Fluoro-4hydroxypropiophenone
• Synonyms: 3Fluoro-4hydroxypropiophenone;1-Propanone, 1-(3-fluoro-4-hydroxyphenyl)-
• CAS NO: 586-16-3
• Molecular Formula: C₉H₉FO₂
• Molecular Weight: 168.16
• Product Categories: Adehydes, Acetals & Ketones;Fluorine Compounds;Phenols
• Mol File: 586-16-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 109–110°C
• Boiling Point: 288.5°C at 760 mmHg
• Flash Point: 128.3°C
• Appearance: /
• Density: 1.2g/cm³
• Vapor Pressure: 0.00135mmHg at 25°C
• Refractive Index: 1.522
• CAS DataBase Reference: 3Fluoro-4hydroxypropiophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 3Fluoro-4hydroxypropiophenone(586-16-3)
• EPA Substance Registry System: 3Fluoro-4hydroxypropiophenone(586-16-3)

Safety Data

• Hazardous Substances Data: 586-16-3(Hazardous Substances Data)

Usage

Preparation

Obtained by demethylation of 3-fluoro-4-methoxy-pro-piophenone with pyridinium chloride at reflux for 15 min.

InChI:InChI=1/C9H9FO2/c1-2-8(11)6-3-4-9(12)7(10)5-6/h3-5,12H,2H2,1H3

Upstream product

• 2357-52-0 3-fluoro-4-methoxyphenyl bromide 
• 331-62-4 3-fluoro-4-methoxybenzonitrile 
• 92821-96-0 propionic acid-(2-fluorophenyl) ester 
• 2105-94-4 4-bromo-2-fluorophenol 
• 104863-65-2 N-methyl-N-methoxypropionamide 
• 367-12-4 2-fluorophenol 
• 79-03-8 propionyl chloride 
• 321-28-8 1-fluoro-2-methoxybenzene 
• 586-22-1 1-(3-fluoro-4-methoxyphenyl)propan-1-one 

Downstream Products

• 86615-79-4 C₉H₈ClFO₂ 
• 577-87-7 2-fluoro-4-(3-methyl-[2]quinolyl)-phenol 
• 343-05-5 2-fluoro-4-(3-methyl-indol-2-yl)-phenol 
• 390-26-1 2-(3-fluoro-4-hydroxy-phenyl)-3-methyl-quinoline-4-carboxylic acid 
• 350-14-1 1-(3-bromo-5-fluoro-4-hydroxy-phenyl)-propan-1-one 

Relevant articles and documents

NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS

The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.

COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS

This invention relates to a method of treating Parkinson's Disease whereby a mammal suffering from Parkinson's Disease is treated with a combination of a forebrain selective NMDA antagonist and a compound which is capable of increasing the excitatory feedback from the ventral lateral nucleus of the thalamus into the cortex. This invention also relates to pharmaceutical compositions containing the synergistic combination.